深海水缩物作为多维生素颗粒的抗积潜力:稳定性和体内活性研究
Barmi Hartesi1,2, Bambang Retnoaji3, Sriwidodo Sriwidodo4
1Doctoral Program, Faculty of Pharmacy, Padjadjaran University, Sumedang, 45363, Indonesia.
Scientific reports
|October 30, 2025
概括
富含矿物质的深海水缩剂被制成稳定,非湿度可观的颗粒. 这些颗粒在斑马鱼中表现出显著的抗发育迟缓活性,为儿童发育迟缓提供了有希望的干预措施.
科学领域:
- 海洋生物技术 海洋生物技术
- 营养科学 营养科学
- 发育生物学 发展生物学
背景情况:
- 儿童发育迟缓是由于严重的营养缺乏导致的.
- 深海水缩剂是一种富含矿物质的多维生素来源.
- 矿物质的吸湿性需要稳定的剂量形式.
研究的目的:
- 开发一种非湿度可观的深海水缩颗粒.
- 为了评估颗粒的物理化学稳定性.
- 在体内评估颗粒的抗衰老潜力.
主要方法:
- 用Avicel PH 102和Florite将深海水缩成颗粒的封装.
- 使用DSC,XRD和SEM进行物理化学分析.
- 在体内使用罗农诱导的斑马鱼胚胎进行的反衰减研究.
主要成果:
- 用Avicel PH 102配制的颗粒在5个月内显示出良好的稳定性.
- 深海水缩剂 (水或颗粒) 提高了斑马鱼化率.
- 治疗增加了斑马鱼的大脑和身体长度,表明抗衰退效应.
结论:
- 深海水缩剂可以成功制成防潮颗粒.
- 开发出来的颗粒具有显著的抗衰减活性.
- 这种配方提供了一个有前途的替代性干预措施,用于儿童发育迟缓.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
Mineral, Vitamin and Water Absorption
1.4K
Electrolytes are essential minerals and ions primarily obtained from the diet and absorbed through the gastrointestinal tract. Most electrolytes are absorbed in the small intestine. While the absorption of iron and calcium primarily occurs in the duodenum, calcium is also absorbed in the jejunum and ileum. In these regions, passive diffusion contributes to its absorption alongside active transport mechanisms in the duodenum. These ions can exit the enterocytes through specialized active...
1.4K
Bioavailability Enhancement: Drug Solubility Enhancement
212
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
212
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
171
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
171
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
177
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
177


